SCHEMBL3402533

SCHEMBL3402533

CCCN(CC1CC1)C1CCN(C(=O)c2sc(-c3ccc(C)c4ccccc34)nc2C)CC1

nearest known ligand 0.56

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
HTR2C P28335 14/20 0.56
CES2 O00748 1/20 0.43
CNR1 P21554 1/20 0.41
OXTR P30559 1/20 0.38
POLB P06746 1/20 0.36
PARP1 P09874 1/20 0.36
CRHR1 P34998 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3405720 0.91 HTR2C (0.68) HTR2CCES2
SCHEMBL3403021 0.90 HTR2C (0.54) HTR2CCES2CNR1OXTRPOLB
SCHEMBL3402132 0.88 HTR2C (0.60) HTR2CCES2CNR1OXTRPOLB
SCHEMBL3402686 0.87 HTR2C (0.46) HTR2CCES2CNR1OXTRCRHR1
SCHEMBL3402440 0.87 HTR2C (0.52) HTR2CCES2CNR1OXTRPOLB
SCHEMBL3403572 0.87 HTR2C (0.52) HTR2CCES2CNR1OXTRPOLB
SCHEMBL13310193 0.86 HTR2C (0.51) HTR2CCES2CNR1OXTRPOLB
SCHEMBL3401307 0.86 HTR2C (0.46) HTR2CCES2CNR1OXTRPOLB
SCHEMBL3404774 0.85 HTR2C (0.45) HTR2CCES2CNR1OXTRCRHR1
SCHEMBL3402416 0.85 HTR2C (0.51) HTR2CCES2CNR1OXTRPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7728009-B1 Thiazole amides, imidazole amides and related analogues NEUROGEN CORPORATION (US) 2010-06-01 US disclosed
US-7728009-B1 Thiazole amides, imidazole amides and related analogues NEUROGEN CORPORATION (US) 2010-06-01 US disclosed
US-7728009-B1 Thiazole amides, imidazole amides and related analogues NEUROGEN CORPORATION (US) 2010-06-01 US disclosed
WO-2006089076-A9 THIAZOLE AMIDES, IMIDAZOLE AMIDES AND RELATED ANALOGUES NEUROGEN CORP (US) 2007-04-26 WO disclosed